Clinical Trial Update: Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating far infrared irradiation for the control, management, and treatment of Amyotrophic Lateral Sclerosis, sponsored by GAAD M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Far Infrared Irradiation

Snippet

Sponsor: GAAD Medical Research Institute Inc. | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: UNKNOWN